en

PRODUCT DETAIL

Repatha 140 mg injekčný roztok naplnený v injekčnom pere

Code 5681B
MA number EU/1/15/1016/003
Product Form: sol inj 2x1 ml/140 mg (striek.inj.skl.napl.SureClick v pere)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10A Lipid modifying agents, plain
C10AX Other lipid modifying agents
C10AX13 Evolocumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.07.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.04.2020
eu-flag.png sk-flag.png